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Abstract.  Two structurally distinct molecular forms of 
acetylcholinesterase are found in the electric organs of 
Torpedo californica. One form is dimensionally asym- 
metric and composed of heterologous subunits.  The 
other form is hydrophobic and composed of homolo- 
gous subunits.  Sequence-specific antibodies were 
raised against a  synthetic peptide corresponding to the 
COOH-terminal  region (Lys56°-Leu s75) of the catalytic 
subunits of the asymmetric form of acetylcholinester- 
ase.  These antibodies reacted with the asymmetric 
form of acetylcholinesterase,  but not with the hydro- 
phobic form.  These results confirm recent studies sug- 
gesting that the COOH-terminal domain of the asym- 
metric form differs from that of the hydrophobic form, 
and represent the first demonstration  of antibodies 
selective for the catalytic subunits of the asymmetric 
form.  In addition,  the reactive epitope of a  monoclo- 
nal antibody (4E7), previously shown to be selective 
for the hydrophobic form of acetylcholinesterase, has 
been identified as an N-linked complex carbohydrate, 
thus defining posttranslational  differences between the 
two forms.  These two form-selective antibodies,  as 
well as panselective polyclonal and monoclonal anti- 
bodies, were used in light and electron microscopic 
immunolocalization  studies to investigate the distribu- 
tion of the two forms of acetylcholinesterase in the 
electric organ of Torpedo. Both forms were localized 
almost exclusively to the innervated surface of the 
electrocytes. However, they were differentially dis- 
tributed along the innervated surface.  Specific 
asymmetric-form immunoreactivity was restricted to 
areas of synaptic apposition and to the invaginations  of 
the postsynaptic membrane that form the synaptic gut- 
ters.  In contrast,  immunoreactivity attributable to the 
hydrophobic form was selectively found along the non- 
synaptic surface of the nerve terminals and was not 
observed in the synaptic cleft or in the invaginations 
of the postsynaptic membrane.  This differential distri- 
bution suggests that the two forms of acetylcholinester- 
ase may play different roles in regulating  the local 
concentration of acetylcholine in the synapse. 
ETYLCHOLINESTERASE Occurs in several structurally 
distinct forms that can be differentiated  biochemi- 
cally by the number and types of subunits they con- 
tain,  the apparent molecular weight  of their catalytic sub- 
units, their sedimentation  behavior, hydrophobicity, and ease 
of extraction (6-8, 12). Although much is also known about 
the kinetics of acetylcholinesterase catalysis,  no functional 
or pharmacological differences between the catalytic sub- 
units  of the diverse structural  forms have been identified. 
Thus the physiological  significance  of the structural  poly- 
morphism probably resides in differential  cellular distribu- 
tion of the individual enzyme forms. Several sensitive assays 
for acetylcholinesterase exist.  However, investigation of the 
distribution  and  biosynthesis of the  individual  forms has 
required their extraction  and identification  on the basis of 
sedimentation constants  or electrophoretic migration  rates 
(14). To investigate structural  differences  and determine the 
relative distribution of the forms of acetylcholinesterase in 
greater detail, we have developed antibodies selective for the 
different  forms  of acetylcholinesterase  found  in  Torpedo 
californica. 
The electric ray Torpedo  californica contains two structur- 
ally distinct classes of acetylcholinesterase in approximately 
equal abundance.  One form is a hydrophobic dimer of cata- 
lytic subunits that aggregate in the absence of detergent,  but 
sediment at 5.6 S in the presence of neutral  detergent  (7). 
This form has been termed the hydrophobic,  globular, or ho- 
mologous  form.  The  COOH-terminal  amino  acid  of this 
form is posttranslationally  modified with a novel glycophos- 
pholipid  (4). The lipid can be removed with a phosphatidyl- 
inositol-specific  phospholipase C,  resulting  in dimers that 
sediment at 5.6 S even in the absence of detergent.  Immuno- 
cytochemical and subcellular fractionation  studies  suggest 
that the hydrophobic form of acetylcholinesterase preferen- 
tially associates  with the presynaptic nerve terminals  (5, 9). 
The  second form of acetylcholinesterase is dimensionally 
asymmetric and composed of two (13 S) or three (17 S) tetra- 
mers of catalytic  subunits linked by disulfide (6, 8) bonds to 
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has been termed the asymmetric or heterologous form. Sub- 
cellular fractionation studies and the collagen-like structure 
of the asymmetric form suggest that this form preferentially 
associates with the basal lamina (6, 8,  12). Mild treatment 
of the asymmetric form with trypsin releases fully active 
tetramers of catalytic subunits that sediment at 11  S (6). 
The complete amino acid sequence of the catalytic sub- 
units of the asymmetric form of acetylcholinesterase from 
Torpedo californica has been determined from sequencing 
the native protein and a cDNA clone (15). Protein sequenc- 
ing of the hydrophobic form has revealed that NH2-termi- 
nal, active site and several other peptide sequences are iden- 
tical in both forms (4,  11). However,  removal of fatty acids 
from the hydrophobic form has allowed isolation and se- 
quencing of a COOH-terminal peptide not found in the asym- 
metric form (4).  The results suggest that both forms share 
an identical amino acid sequence through Thr  535, where they 
diverge.  The  hydrophobic form continues for two amino 
acids (Ala-Cys), while the asymmetric form continues for 40 
amino acids. Recent isolation of genomic clones from Tor- 
pedo has revealed the genomic organization of acetylcholines- 
terase  (16, and unpublished results).  It appears  that both 
forms of acetylcholinesterase share the same two exons that 
code for the first 535 amino acids, and that their differences 
are the result of alternate splicing of third exons coding for 
their divergent COOH-terminal regions. 
To generate antibodies selective for the asymmetric form, 
we prepared polyclonal antibodies to a synthetic peptide cor- 
responding to a region found only in the COOH-terminal do- 
main of the asymmetric form. In addition, we have identified 
the antigenic determinant ofa monoclonal antibody (4E7) al- 
ready shown to be selective for the hydrophobic form (3). 
Immunolabeling of cryosections of electric organ with anti- 
bodies reacting with sequences that are either common or 
unique to the two forms of acetylcholinesterase has allowed 
us  to determine the differential distribution of acetylcho- 
linesterase forms with respect to  synaptic specializations. 
Several antibody probes were used, including: (a) COOH- 
terminal,  sequence-specific  rabbit  polyclonal  antibodies 
(CT) that selectively recognize the catalytic subunits of the 
asymmetric form; (b) a mouse monoclonal antibody (4F3) 
that selectively recognizes the collagen-like structural sub- 
unit of the asymmetric form; (c) a mouse monoclonal anti- 
body (4E7) that selectively recognizes the catalytic subunits 
of the hydrophobic form; (d) rabbit polyclonal antibodies 
(80A and 80B) that recognize the catalytic subunits of both 
forms;  and (e)  a  mouse monoclonal antibody (2C9)  that 
recognizes a sequence common to the catalytic subunits of 
both forms. 
Materials and Methods 
Materials 
The 5.6 S hydrophobic form of acetylcholinesterase and the 1  l  S tetramer 
of catalytic subunits derived from the asymmetric form of acetylcholinester- 
ase were purified from Torpedo californica (6-8). They were labeled with 
3H-DFP (0.36  Ci/mmol), and reduced and alkylated as described previ- 
ously (11). Reagents for SDS-PAGE were obtained from Bio-Rad Laborato- 
ries (Cambridge, MA). Glycopeptidase F (25,000  U/mg) endoglycosidase 
F  (600  U/mg), and endoglycosidase H  (40  U/mg), were obtained from 
Boehringer Mannheim Diagnostics (Houston, TX). Pansorbin, a suspen- 
sion of fixed protein A bearing Staphylococcus aureus cells, was obtained 
from Calbiochem-Behring Corp. (San Diego, CA). Monoclonal antibodies 
4E7 and 4F3 were obtained in a previous study (3). Monoclonal antibodies 
2C9 and 2C6 were obtained using similar procedures except that the antigen 
was DFP labeled, denatured, reduced, and alkylated, 11 S acetylcholines- 
terase. Monoclonal antibodies were purified from cell culture supernatants 
by precipitation with 50%  (NH4)2SO4, as described previously (3). 
Production of Site-directed Antibodies 
A  hexadecapeptide corresponding  to  the  COOH-terminal  amino  acids 
(KNQFDHYSRHESCAEL, Lys56°-Leu 575) of the catalytic subunits of the 
asymmetric form of acetylcholinesterase was synthesized in the laboratory 
of Dr.  Russell  Doolittle  (University  of California,  San  Diego)  by  the 
Merrifield solid phase method (t4C-labeled amino acids were included to 
give a specific activity of 7.8 mCi/mol). The authenticity of the peptide was 
determined by gas-phase sequencing on a protein sequencer (model 470A; 
Applied Biosystems Inc., Foster City, CA). The peptide was coupled to BSA 
by slowly adding glutaraldehyde (1 ml, 0.2%) to 2 ml of 100 mM sodium 
phosphate buffer (pH 7.5) containing 1.5  ×  10 -7 mol (10 rag) of BSA and 
7.6 ×  10  -6 mol of peptide. The reaction was allowed to proceed for 30 min 
at 22°C, and then unreacted glutaraldehyde was quenched by the addition 
of 0.25 ml of 1.0 M glycine. The result of the coupling reaction was evalu- 
ated by SDS-PAGE. The reduced migration of the peptide-BSA conjugate 
corresponded to an average incorporation of 5-10 mol of peptide per mole 
of BSA. In addition, the peptide-BSA conjugate was excised from the gel, 
dissolved in 0.5 ml formic acid (80°C, 4 h), and neutralized by addition of 
0.5 ml of 1.0 M Tris-HCl (pH 7.0). The radioactivity incorporated into the 
BSA was consistent with an average incorporation of 4-5 mol of peptide per 
mole of BSA. 
Female white New Zealand rabbits (5-6 lbs) were immunized by injec- 
tion in the isolated lymph nodes of the rear leg and intradermally down the 
back with 0.8 ml containing 0.4  ml peptide-BSA conjugate (1.54  mg/ml 
BSA) and 0.4 rnl Freund's complete adjuvant. Booster immunizations were 
performed intradermally after 1 mo and 50 ml of blood was drawn 2 wk 
later.  The serum was allowed to clot at 22°C, clarified by centrifugation, 
and frozen at  -70°C in small aliquots. 
SDS-PAGE and Western Blots 
Proteins were mixed with an equal volume of buffer containing 30 mM Tris- 
HCI (pH 6.8),  1.0% SDS, 5% glycerol, 10 mM DTT,  0.05 mg/ml brom- 
phenol blue, and 0.05 mg/ml pyronin Y. Samples were boiled for 3 min and 
proteins were separated by discontinuous SDS-PAGE in 1.5-ram  slab gels 
composed  of  a  constant  ratio  of  acrylamide  and  N,N'-methylene-bis- 
acrylamide (3771) polymerized with ammonium persulfate (0.75 mg/ml) and 
N,N,N',N',-tetramethylethylenediamine (0.67 #l/ml).  The stacking gel was 
3.3% acrylamide in 25 mM Tris-HCl (pH 6.8), 0.2% SDS, and the separat- 
ing gel was either 8 or 10% acrylamide in 75 mM Tris-HC1 (pH 8.6), 0.2% 
SDS. The gels were run in a slab gel apparatus (model SE 500;  Bio-Rad 
Laboratories) at  120 V constant voltage in 25 mM Tris,  190 mM glycine 
(pH 8.6), 0.1% SDS. Proteins were detected in the gels by staining and de- 
staining in the presence and absence, respectively, of Coomassie brilliant 
blue R (0.15 mg/ml) in 50%  methanol, 10%  acetic acid. 
Electrophoretic transfer (50 V, 150 mA, 4°C, 10-16 h) of proteins from 
unstained gels to nitrocellulose was performed in a transphor unit (TE Se- 
ries; Hoefer Scientific Instruments, San Francisco, CA) after soaking the 
gel in the transfer buffer (25 mM Tris, 190 mM glycine, pH 8.6, 20% metha- 
nol) for 30 min. Blotted proteins were detected by staining and destaining 
in 50% methanol, 10% acetic acid, in the presence or absence, respectively, 
of Amido black (0.1 mg/ml). Immunodetection of blotted proteins was per- 
formed using a Vectastain ABC kit (Vector Laboratories, Inc., Burlingame, 
CA) that uses a biotin-labeled goat anti-rabbit antibody and peroxidase- 
coupled avidin. 
Deglycosylation of  Acetylcholinesterase 
The deglycosylation reactions used 3H-DFP-labeled acetylcholinesterase 
that had been desalted on a size exclusion column, and then lyophylized. 
3H-DFP-labeled acetylcholinesterase (1.09  rag)  was  resuspended in  50 
mM sodium phosphate buffer (pH 6.1) containing 50 mM EDTA,  1 mM 
PMSE  10 #M pepstatin A, 0.5%  NP-40, 0.5% ~-mercaptoethanol, 0.1% 
SDS, and digested with endoglycosidase F (20 U) by incubation for 8 h at 
37°C.  3H-DFP-labeled acetylcholinesterase (1.76 mg) was deglycosylated 
The Journal  of Cell Biology,  Volume 108, 1989  2302 with glycopeptidase F (1.0 U) by incubation in 1.1 ml of 250 mM sodium 
phosphate buffer (pH 7.4) containing 10 mM EDTA, 1.0 mM PMSF, 10 #M 
pepstatin A, 0.8% NP-40, 10 mM ~-mercaptoethanol, 0.5% SDS, for 18 h 
at 37°C.  3H-DFP-labeled acetylcholinesterase (2 mg) was treated for 8 h 
at 37°C with endoglycosidase H (1.0 U) in 0.1 M sodium citrate buffer (pH 
5.5) containing !.0 mM PMSE  10 mM pepstatin A, 2% SDS, and  1.0% 
~-mercaptoethanol. 
lmmunoprecipitation of  Acetylcholinesterase 
3H-DFP-labeled acetylcholinesterase (0.4 #g) was incuba~l with the indi- 
cated antibodies in 200 ml of buffer A containing 20 mM sodium phosphate 
(pH 7.4),  150 mM NaCl, 0.02%  NAN3, 0.01% Tween-20, and 0.1%  BSA 
for 2  h at 37°C.  Pansorbin was washed with buffer A containing 5  mM 
b-mercaptoethanol, and 0.5 % NP-40, then washed with buffer A containing 
0.05%  NP-40, and finally resuspended to 2.5% (wt/vol) in buffer A. Anti- 
bodies were precipitated by the addition of 800/zl of Pansorbin (15 min at 
4°C). Precipitates were sedimented by centrifugation in a microfuge, the su- 
pernates aspirated, and the pellets resuspended by incubation with 200/~l 
of 2 % SDS and 4 M urea at 90°C for 2 rain. The Pansorbin was separated 
from the solubilized acetylcholinesterase by centrifugation in a microfuge, 
and the supernatant removed for determination of radioactivity.  Precipita- 
tion of 3H-DFP-labeled acetylcholinesterase by the antibodies was com- 
pared to the maximal precipitation obtained by the addition of 1.O ml of ace- 
tone rather than Pansorbin. 
Preparation of Tissue  for Light and 
Electron Microscopy 
The electric organs were removed from an adult male Torpedo and fixed 
in 4%  paraformaldehyde in 0.1  M  PBS  for  1 h  at 4°C.  The tissue was 
trimmed down to 'x,3  x  2-mm pieces and cryoprotected in 1.0 M sucrose 
with 0.5% paraformaldehyde in 0.1 M PBS for 30 min at 4°C followed by 
2.0 M sucrose with 0.5% paraformaldehyde in 0.1 M PBS for 1 h at 4°C. 
Tissue was then mounted on aluminum specimen support pins so as to pro- 
vide a cross section of the electrocytes and frozen in liquid propane cooled 
with liquid nitrogen. 
Conventional electron microscopy was performed using small pieces of 
electric organ that were first fixed in 2% glutaraldehyde and 2% parafor- 
maldehyde in PBS for 1 h, followed by 1% osmium tetroxide for 1 h. After 
dehydration with ethanol, the tissue was embedded in EPON-Araldite resin. 
Ultrathin sections were counterstained with uranyl  acetate and lead citrate. 
Immunofluorescent Localization of 
Acetylcholinesterase 
Thick sections (2-p.m) of frozen tissue were cut on a ultracryomicrotome 
(model FC-4D; Reichert Scientific Instruments, Buffalo, NY) at -80°C and 
mounted on clean glass slides using a drop of 2.0 M sucrose in a platinum 
loop. Sections were reequilibrated with 0.1 M PBS followed by 0.1 M PBS 
with 0.05 M glycine for 5 min. To minimize nonspecific staining the sections 
were pretreated with 1% gelatin in PBS for 10 min followed by 2% normal 
goat sera (Organon Teknika-Cappel, Malvern, PA) in PBS for 10 min. Sec- 
tions were incubated in specific antisera or normal rabbit or normal mouse 
sera for 30 min at room temperature. Dilutions of primary antibodies were 
80B (100x),  2C9 (100x), 4F3 (50×),  CT (100×),  4E7 (100×),  and an- 
tireceptor antibodies (100x). After extensive washing in PBS, the sections 
were treated with either goat anti-rabbit rhodamine or goat anti-mouse 
fluorescein conjugate (Organon Teknika-Cappel) for 20 min. The sections 
were again washed extensively in PBS, covered with 90% glycerol in PBS, 
and placed under a coverslip. Sections were examined using a Leitz 63x 
objective on a Zeiss universal microscope, and were photographed with Ko- 
dak T-Max 400 ASA film and a Nikon UFX camera system. 
Electron Microscopic Localization of 
Ac  etylc  holineste  rase 
Thin  cryosections (0.1 rim)  or thick cryosections (0.5  /zm)  were cut at 
-II0°C and mounted on Formvar filmed carbon stabilized gold grids. The 
sections were treated much like the thick sections except after incubation 
in primary antisera the sections were immunolabeled with goat anti-rabbit 
or goat anti-mouse IgG conjugated to either 5, 10, 15, or 30 nm gold (Jans- 
sen Life Sciences Products, Piscataway,  NJ) for 20 rain.  After extensive 
washing in PBS the sections were fixed in 1% glutaraldehyde/l% osmium 
tetroxide in PBS for 3 min.  Sections were washed in distilled water and 
counterstained in 2% aqueous uranyl acetate for 30 min. The sections were 
subsequently dehydrated in ethanol and embedded in a thin film of LR white 
acrylic resin (Ted Pella, Inc., Irvine, CA) and polymerized as previously 
described (20).  Thin cryosections were viewed at  100 KeV with a JEOL 
100CX electron microscope, and thick cryosections were viewed at 1 MeV 
with a JEM  1,000 high voltage electron microscope. 
Results 
Biochemical Characterization of  Antibodies Used 
for lmmunolocalization 
Polyclonal antibodies raised against a synthetic peptide cor- 
responding to the COOH-terminal sequence of the asymmet- 
ric form of acetylcholinesterase (CT) were tested for their 
ability  to precipitate  3H-DFP-labeled acetylcholinesterase 
(Fig. 1). Antibodies raised against the COOH-terminal pep- 
tide  precipitated the  catalytic subunits  of the  asymmetric 
form  of acetylcholinesterase (11  S  enzyme),  but  did  not 
precipitate the hydrophobic form of acetylcholinesterase (5.6 
S enzyme). 
The reactivity of antibodies 2C9, 4E7, and CT was deter- 
mined by Western blots of the 11 S and 5.6 S forms of acetyl- 
cholinesterase (Fig. 2). The reduced monomers and irreduc- 
ible dimers of the two forms can be distinguished by the 
slightly  larger apparent  molecular weight of the catalytic 
subunits of the 11 S form (7). The monoclonaI antibody 2C9 
reacted equally well with both forms. However, the mono- 
clonal antibody 4E7  selectively recognized only the 5.6 S 
form of the enzyme. As was the case in the immunoprecipita- 
tion assay (Fig.  1), the polyclonal antibody CT selectively 
recognized only the 11 S form of acetylcholinesterase (Fig. 
2). Although the CT antibodies didn't react as well with the 
irreducible dimer as with the monomer, reactivity with the 
irreducible dimer was observed when the concentration of 11 
S or the CT antibodies was increased. The reactivity of the 
CT antibodies was completely blocked by earlier incubation 
of the antibodies with the peptide (2.8  ×  10  -7 M) to which 
the rabbit was immunized, and was not affected by earlier in- 
cubation with the same concentration of a synthetic peptide 
8O 
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Figure I. Immunoprecipitation of 11 S and 5.6 S acetylcholinester- 
ase. Both forms of acetylcholinesterase were reacted with 3H-DFP, 
denatured,  reduced,  and alkylated as described in Materials  and 
Methods.  The ability of the COOH-terminal  directed antibodies 
(CT) to precipitate  11  S  (e) and 5.6 S  (m) forms of acetylcholin- 
esterase is plotted as a  percentage of 3H-DFP-labeled acetylcho- 
linesterase precipitated by acetone versus the fold dilution of CT. 
Abramson et al. Molecular Forms of Acetytcholinesterase  2303 Figure 2.  Western blots of 11  S and 5.6 S acetylcholinesterase. 
Equal amounts (10 #g/lane) of the 11 S enzyme derived from the 
asymmetric form (lane 1) and the 5.6 S hydrophobic form (lane 2) 
were denatured in Lammeli buffer, including DTT (50 mM), by 
boiling for 2 min. Proteins were separated by SDS-PAGE on an 8  % 
polyacrylamide gel, transferred to nitrocellulose, and reacted with 
the monoclonal (1:1,000 dilution) or polyclonal  (h 100 dilution) anti- 
bodies as described in Materials and Methods. The positions of 
protein standards are indicated. 
corresponding to the active-site region of the enzyme (data 
not shown). 
Since the 5.6 S hydrophobic form of acetylcholinesterase 
is thought to contain only two amino acids not found in the 
11 S asymmetric form (4, 16, 19), the basis of the selectivity 
of  4E7 was investigated further. Glycopeptidase F selectively 
cleaves  N-linked  carbohydrates  between  asparagine  and 
the proximal N-acetylglucosamine. Digestion of 3H-DFP- 
labeled  5.6  S  acetylcholinesterase with glycopeptidase F 
resulted in an almost complete loss of the ability of 4E7 
to precipitate the enzyme (Fig. 3 A). Complete removal of 
N-linked carbohydrate was demonstrated by a decrease in the 
apparent molecular weight of 5.6 S acetylcholinesterase in 
SDS-PAGE after treatment with glycopeptidase F (Fig. 3 A, 
inset). The complexity of the carbohydrate was assessed fur- 
ther by digestion with endoglycosidase F and H. Digestion 
of  3H-DFP-labeled  5.6  S  acetylcholinesterase  with  en- 
doglycosidase F  resulted in an almost complete loss of the 
ability of 4E7 to precipitate the enzyme (Fig.  3 B), while 
digestion with endoglycosidase H was without effect (Fig. 3 
B, inset). These results suggest that the antigenic determinant 
of 4E7 is a complex-type N-linked carbohydrate. The ability 
of 2C9 to precipitate 3H-DFP-labeled acetylcholinesterase 
was not affected by similar treatments with these glycohydro- 
lases (data not shown). 
lmmunocytochemical Localization of 
Acetylcholinesterase 
Several  antibodies  against acetylcholinesterase have  been 
generated, characterized biochemically, and examined for 
their usefulness in immunocytochemical assays (Table  I). 
Those with particularly interesting biochemical properties 
and  relatively strong  immunoreactivity, were  used  to  in- 
vestigate the distribution of the different forms of acetyl- 
cholinesterase in the electric organ of Torpedo californica. 
Antibodies  chosen  for  further  study  included:  (a)  the 
COOH-terminal  site-directed rabbit  polyclonal antibodies 
(CT) that selectively recognize the catalytic subunits of the 
asymmetric form; (b) the mouse monoclonal antibody (4F3) 
that selectively recognizes the collagen-like structural sub- 
unit of the asymmetric form; (c) the mouse monoclonal anti- 
body (4E7) that selectively recognizes the catalytic subunits 
of  the hydrophobic form; (d) the rabbit polyclonal antibodies 
(80A and 80B) that recognize the catalytic subunits of both 
forms; and (e) the mouse monoclonal antibody (2C9)  that 
recognizes a sequence in the catalytic subunits common to 
both forms.  Polyclonal antibodies raised against nicotinic 
acetylcholine receptors  purified  from  Torpedo (10) were 
used to compare the localization of  acetylcholinesterase with 
the nicotinic receptor. 
The ultrastructure of the Torpedo electric organ is well- 
characterized (14, 17). The ventral surface of  the electrocytes 
is densely innervated by elongated presynaptic nerve termi- 
nals that lie in shallow trough-like depressions in the post- 
synaptic membrane. In addition, the postsynaptic membrane 
contains many finger-like tubular invaginations that occur at 
irregular intervals. Immunofluorescent localization of ace- 
tylcholinesterase by light microscopy using either the pan- 
selective polyclonal antibody 80B or the panselective mono- 
clonal antibody 2C9 revealed that acetylcholinesterase-like 
immunoreactivity was  confined almost exclusively to  the 
ventral innervated surface of the electrocytes (Fig. 4, A and 
B). The finger-like invaginations of the postsynaptic mem- 
brane appeared to contain intense staining. However, reactiv- 
ity was also evident across the entire ventral surface of the 
electrocytes. 
The distribution of the form-selective antibodies was strik- 
ingly different from that of the panselective antibodies. Anti- 
bodies selective for the collagen-like subunit (4F3) and cata- 
lyric  subunit  (CT)  of  the  asymmetric  form  revealed  a 
somewhat punctate distribution, and this form of the enzyme 
appeared to be concentrated in the invaginations of the post- 
synaptic membrane (Fig. 4, C and E, respectively). In con- 
trast, the monoclonal antibody selective for the hydrophobic 
form (4E7), revealed a distinctly different distribution (Fig. 
4  D).  At the innervated surface of the electrocyte the im- 
munoreactivity of 4E7 appeared discontinuous and was not 
observed in the invaginations of the postsynaptic membrane. 
The antibody 4E7 also appeared to react moderately with an 
unknown antigen on the noninnervated surface of the elec- 
trocyte. 
Higher magnification of tissue sections allowed the distri- 
bution of acetylcholinesterase immunoreactivity to be deter- 
mined within the substructure of the synaptic specializations 
(Fig. 5).  The panselective antibody 2C9 stained the nerve 
terminals, as well as the invaginations of the postsynaptic 
membrane (Fig. 5 A). The antibody selective for the hydro- 
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ity of  4E7 to precipitate 5.6 S acetylcholinester- 
ase.  3H-DFP-labeled  5.6  S  aeetylcholinester- 
ase was  treated  with either  glycopeptidase F 
(.4) or endoglycosidase F  (B) as described in 
Materials and Methods. The ability of 4E7 to 
precipitate control  (e)  or treated (a)  enzyme 
is plotted as a  percentage of 3H-DFP-labeled 
aeetyleholinesterase  precipitated  by  acetone 
versus  the  fold dilution  of 4EZ  (Inset in A) 
Control 0ane 1) and glycopeptidase F-treated 
(lane 2) 5.6 S enzyme were separated by SDS- 
PAGE on a  10% polyaerylamide gel and visual- 
ized by silver staining. (Inset in B) The ability 
of 4E7 to precipitate control, endoglycosidase 
F-, or endoglycosidase H-treated 5.6 S enzyme 
is shown. 
Table L Staining Intensity of  Antibodies Used in Immunocytochemical Localization of 
Acetylcholinesterase in Torpedo  Electric Organ 
Antigen  Name  Species  Poly/Mono  Subtype  Light  EMperox  *  EMgold¢  Form§  Reference 
11  S  80A  Rabbit  Polyclonal  -  +  +  +  +  +  +  +  +  Both  6,8 
11  S  80B  Rabbit  Polycional  -  +  +  +  +  +  +  Both  6,8 
17  S,  5.6  S  4E7  Mouse  Monoclonal  IgG2b  +  +  +  +  +  +  5.6  S  3 
17  S,  5.6  S  4F3  Mouse  Monoclonal  IgGl  +  +  +  +  17  S  3 
11  S  2C9  Mouse  Monoclonal  IgGl  +  +  +  ND  +  +  +  Both  - 
11  S  2C6  Mouse  Monocional  lgG 1  +  +  +  +  +  +  ND  - 
Peptidefl  CT  Rabbit  Polycional  -  +  +  +  +  +  +  +  17  S  - 
Peptidel  AS  Rabbit  Polycional  -  -  ND  ND  Both  - 
* Results  obtained  with the electron microscope and peroxidase-labeled secondary antibodies. 
~: Results obtained with the electron microscope and gold-labeled secondary antibodies. 
§ Molecular form of acetylcholinesterase  (5.6 S,  17 S, or both) recognized by the antibody  is indicated. 
tl Synthetic peptide Lysr'6°-Leu  sTs, corresponding to the COOH-terminal  amino acids of the catalytic  subunit of the asymmetric form of acetylcholinesterase  from 
Torpedo californica, was used as the antigen. 
I The synthetic peptide Lys~92-Arg  2'6, corresponding to amino acids common to both forms of acetylcbolinesterase  from Torpedo californica, was used as the 
antigen. 
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5 B), while the antibodies selective for the asymmetric form 
(4F3 and CT) selectively stained the synaptic cleft and the 
invaginations of the postsynaptic membranes (Fig. 5, C and 
D,  respectively).  Single  sections double-labeled  with the 
monoclonal antibody 4E7 (Fig. 5 E) and polyclonal antibod- 
ies selective for the nicotinic acetylcholine receptor (Fig. 5 
F) allowed the structures containing the hydrophobic form 
of acetylcholinesterase to be compared with those containing 
the receptor.  Arrows indicate the positions of nerve terminals 
that react strongly with 4E7 (Fig. 5 E). Arrows at identical 
positions indicate that many of the nerve terminals can be 
seen to lie in shallow trough-like depressions in the post- 
synaptic membrane (Fig. 5 F). 
Further resolution was obtained by electron microscopy. 
Conventionally stained and embedded sections of  electric or- 
gan revealed elongated nerve terminals and the finger-like in- 
vaginations of the postsynaptic membrane (Fig. 6). In addi- 
tion, thin Schwann cell processes could be observed covering 
the nonsynaptic surface of some, but not all, of the nerve ter- 
minals. Electron microscopy of immunogold-labeled ultra- 
thin cryosections also revealed elongated nerve terminals cut 
in longitudinal (Fig. 7 A) or cross section (Fig. 7 B). The 
panselective monoclonal antibody (2C9) reacted with acetyl- 
cholinesterase-like antigens in the invaginations of the post- 
synaptic membrane, in the synaptic cleft, and on the non- 
synaptic surface of the nerve terminals (Fig. 7 A, 5-nm gold, 
arrowheads).  In the same section, however, the asymmetric 
form-selective polyclonal antibodies (CT) selectively stained 
the synaptic cleft and the invaginations of the postsynaptic 
membrane (Fig. 7 A, 10-nm gold, arrows).  Immunoreactiv- 
ity attributable to the asymmetric form was not detected on 
the nonsynaptic surface of the nerve terminals. In contrast, 
the hydrophobic form-selective monoclonal antibody (4E7) 
selectively stained the nerve terminals, and the distribution 
of gold particles was restricted to the nonsynaptic surface of 
the nerve terminals (Fig. 7 B, 5-nm gold). Immunoreactivity 
attributable to the hydrophobic form was not detected in the 
synaptic cleft or the invaginations of the postsynaptic mem- 
brane. 
Discussion 
Since the various structural forms ofacetylcholinesterase  are 
kinetically and pharmacologically indistinguishable, their 
physiological significance may reside  in  their  differential 
distribution.  Studies  of  the  distribution  of the  different 
structural forms of acetylcholinesterase have been severely 
limited by the necessity to isolate the different forms and 
characterize them biochemically. Nonetheless, there is evi- 
dence that suggests the two forms of acetylcholinesterase in 
Torpedo are differentially  distributed. For instance, while the 
asymmetric form is presumably associated with the basal 
lamina based on its dissociation with collagenase, the hydro- 
phobic form can be concentrated with highly purified synap- 
tosomes prepared from Torpedo electric organ (9, 13). To al- 
low more detailed investigation into the distribution of the 
different structural forms of acetylcholinesterase, we have 
undertaken the development and characterization of form- 
selective antibodies for use in high resolution in situ immu- 
nocytochemistry. 
Several groups have raised polyclonal and monoclonal an- 
tibodies to acetylcholinesterase, and a comprehensive review 
of the existing antibodies has been compiled (2).  Since the 
sequence of the first 535  amino acids is the same for both 
forms of the enzyme,  it is  not surprising that few form- 
selective monoclonal antibodies have been generated using 
the entire protein as an antigen. However,  monoclonal anti- 
bodies that appear to react selectively with the hydrophobic 
form of acetylcholinesterase have been reported (1, 3, 5). In 
one case, purified synaptosomes from the electric organ of 
Torpedo californica were used as the antigen (5).  A mono- 
clonal antibody (Tor 23) was isolated, and shown to selec- 
tively precipitate the hydrophobic form of acetylcholinester- 
ase and to selectively stain nerve terminals in Torpedo back 
muscle. However, the antigenic determinant of this antibody 
has yet to be identified. In another case, an IgM monoclonal 
antibody (Elec-39)  selective for the hydrophobic form of 
Torpedo  acetylcholinesterase was  obtained  by  using  the 
asymmetric form of the enzyme from Electrophorus electric 
organ as the antigen (1). This antibody was shown to react 
with several other proteins in addition to acetylcholinester- 
ase, and the reactive epitope for this antibody was shown to 
be a carbohydrate sensitive to treatment by endoglycosidase 
E  This antibody, however,  was not used for immunocyto- 
chemical localization of acetylcholinesterase. 
Since the hydrophobic form contains only two amino acids 
not found in the asymmetric form, it seems likely that all hy- 
drophobic form-selective antibodies recognize posttransla- 
tional modifications found only on this form. Therefore, we 
investigated the effects of several glycohydrolases  on the abil- 
ity of  the hydrophobic-form selective antibody 4E7 to precip- 
itate acetylcholinesterase. Deglycosylation with either gly- 
copeptidase F or endoglycosidase F resulted in a complete 
loss of the ability of 4E7 to precipitate 5.6 S acetylcholin- 
esterase, while treatment with endoglycosidase H was with- 
out effect. Therefore, the antigenic determinant for 4E7 ap- 
pears  to be a  complex-type N-linked carbohydrate.  Since 
4E7 was the only antibody to react with the noninnervated 
surface of the electrocytes, the antigenic determinant for 4E7 
appears to be shared by an unknown protein on the noninner- 
vated surface of the electrocytes. 
The position of  the amino acid containing the carbohydrate 
identified by 4E7 has yet to be determined. However,  both 
forms of acetylcholinesterase contain four identical potential 
sites for N-linked carbohydrate (asparagine residues 59, 416, 
457, and 533). Peptides containing each of the four potential 
glycosylation sites have been isolated from the asymmetric 
form,  and  each  of the  four  sites  has  been  shown to  be 
glycosylated (unpublished  observations).  Thus  the  selec- 
tivity of 4E7 likely results from a distinct complex-type car- 
bohydrate found only on the hydrophobic form, rather than 
Figure 4. Immunofluorescent localization of acetylcholinesterase in Torpedo electric organ. Tissue sections were prepared as described 
in Materials and Methods and were incubated with either (A) 80B, (B) 2C9, (C) 4F3, (/9) 4E7, (E) CT, or (F) CT antibodies blocked 
by earlier incubation with the COOH-terminal peptide (2.8  x  10  -7 M). These primary antibodies were visualized with rhodamine or 
fluorescein-labeled secondary antibodies. Bar, 10 t~m. 
Abramson et al. Molecular  Forms of Acetylcholinesterase  2307 Figure 5. High magnification of immunofluorescent staining. The primary antibodies were (A) 2C9, (B) 4E7, (C) 4F3, and (D) CT. Tissue 
sections were also double labeled with 4E7 (E) and antibodies selective for the nicotinic acetylcholine receptor (F). The same section 
is shown in both E and F, where the primary antibodies were visualized with fluorescein and Texas red-labeled  secondary antibodies, respec- 
tively. The arrows (identical positions in both E and F) indicate nerve terminals stained by 4E7 (E) that lie in shallow troughs in the post- 
synaptic membrane (F). Bars,  10 ~m. 
The Journal of Cell Biology, Volume 108, 1989  2308 Figure 6. Electron micrograph of conventionally fixed and embedded electric organ. An elongated nerve terminal is shown. Some  of the 
nonsynaptic surface of the nerve terminal is covered by a thin Schwann  cell process (arrowheads), while most of the nonsynaptic surface 
of the nerve terminal is without the Schwann cell covering (arrows). Finger-like invaginations  of the postsynaptic membrane are indicated 
with asterisks. Bar, 1 #m. 
from a unique site of glycosylation. Although the physiologi- 
cal  significance of this difference in posttranslational gly- 
cosylation is not known, it is interesting to speculate that per- 
haps it allows for differential association with extracellular 
matrix components or cell-cell associations. 
Antibodies raised against a synthetic peptide correspond- 
ing to the COOH-terminal 16 amino acids of the asymmetric 
form of acetylcholinesterase were shown to be selective for 
the asymmetric form by both Western blot and immunopre- 
cipitation assays. These results provide further evidence for 
the divergent COOH  termini of the two  forms of acetyl- 
cholinesterase. In addition, they represent the first report of 
an antibody selective for the catalytic subunits of the asym- 
metric form. Since it is likely that the genomic organization 
of acetylcholinesterase is similar in different species,  this 
method of generating asymmetric form-selective antibodies 
should prove successful in other species. 
The generation of antibodies with defined antigenic deter- 
minants  that  are  selective  for  the  two  forms  of acetyl- 
cholinesterase has allowed us to investigate their differential 
distribution in the electric organ of Torpedo californica.  At 
the light microscopic level panselective antibodies (80B and 
2C9) revealed a relatively uniform labeling of the innervated 
surface of the electrocytes. The higher resolution provided 
by electron microscopy revealed that acetylcholinesterase- 
like immunoreactivity was located in the invaginations of the 
postsynaptic membrane, in the synaptic cleft, and on the non- 
synaptic surface of the nerve terminals. In contrast, the dis- 
tribution of the asymmetric form-selective antibodies was 
more punctate, and at the light microscopic level it appeared 
that the asymmetric form was concentrated in the synaptic 
cleft and in the invaginations of the postsynaptic membrane. 
Electron microscopy confirmed that the immunoreactivity 
attributable to the asymmetric form was restricted to the syn- 
aptic cleft and to the invaginations of the postsynaptic mem- 
brane. Similar results were obtained for antibodies directed 
against the collagen-like tail subunit (4F3)  or the unique 
amino acid sequence found only in the catalytic subunits of 
the asymmetric form (CT). 
Since acetylcholinesterase-like immunoreactivity was ob- 
served on the nonsynaptic surface of the nerve terminals, and 
since the asymmetric form-selective antibodies did not react 
with the  nonsynaptic surface  of the  nerve terminals,  the 
acetylcholinesterase-like  immunoreactivity  found  on  the 
nonsynaptic surface of the nerve terminals presumably rep- 
resented the hydrophobic form of the enzyme. This conclu- 
sion  was  confirmed  by  localization  of  the  hydrophobic 
form-selective antibody 4E7. At the light microscopic level 
4E7 appeared to react selectively with the nerve terminals. 
The greater resolution provided by electron microscopy re- 
vealed that 4E7 reacted exclusively with the nonsynaptic sur- 
face of the nerve terminals. Thus, by virtue of its inability 
to react with asymmetric form-selective antibodies and its 
ability  to  react  with  the  panselective  and  hydrophobic 
form-selective antibodies, the acetylcholinesterase-like im- 
munoreactivity on the nonsynaptic surface of the nerve ter- 
minals appears  to  represent  the hydrophobic form of the 
enzyme. 
Since  all  of  the  nerve  terminals  examined  contained 
acetylcholinesterase-like  immunoreactivity  on  their  non- 
synaptic surfaces (identified with either nonselective or hy- 
drophobic form-selective antibodies), the enzyme is proba- 
bly located on the neuronal membrane. However, some of  the 
nerve terminals are covered by thin Schwann cell processes 
(14,  17). These  thin  Schwann  cell  processes  were  more 
difficult to resolve in the ultrathin cryosections used for im- 
munocytochemistry than in the conventionally stained and 
embedded sections. Therefore, the possibility remains that 
some of the acetylcholinesterase-like immunoreactivity is 
associated with these thin Schwann cell processes rather than 
with the nerve terminals themselves. 
Although both  forms  of acetylcholinesterase hydrolyze 
acetylcholine, their differential cellular localization suggests 
that they may have slightly different functions. Since the 
asymmetric form appeared concentrated in the extracellular 
space between the nerve terminal and the electrocyte, it may 
be the form primarily responsible for the rapid hydrolysis of 
acetylcholine in the synaptic cleft. In contrast, the hydropho- 
bic form was located on the nonsynaptic surfaces of  the nerve 
terminals, and may therefore be responsible for hydrolysis of 
acetylcholine  that has diffused from the synaptic cleft. Selec- 
tive manipulation of expression of the two forms of acetyl- 
Abramson et al. Molecular Forms of Acetylcholinesterase  2309 Figure 7. Electron micrographs of cryosections of electric organ. (A) Tissue section showing an elongated nerve terminal cut in longitudinal 
section, double-labeled with 2C9 and CT, and visualized with 5- and 10-nm colloidal gold-conjugated  secondary antibodies, respectively. 
Arrows indicate  10-nm gold found only in the invaginations of the postsynaptic membrane and in the synaptic cleft,  while arrowheads 
indicate 5-nm gold found in the invaginations of the postsynaptic membrane,  in the synaptic cleft, and on the nonsynaptic surface of the 
nerve terminals.  (B) Tissue section showing elongated nerve terminals cut in cross section,  labeled with 4E7, and visualized with 5-nm 
gold.  Arrowheads  indicate the 5-nm gold found selectively on the nonsynaptic surface of the nerve terminals.  Bars,  1 ttm. 
cholinesterase may be required to fully assess the functional 
role of each form. 
The present study extends our understanding of the cellu- 
lar  location of the  two forms of acetylcholinesterase,  and 
provides a more direct localization of these final gene prod- 
ucts.  However, the origin of synthesis of the two forms re- 
mains unknown. Synthesis of acetylcholinesterase could oc- 
cur in the electrocytes or Schwann cells of the electric organ, 
or in the electromotor neurons of the electric lobe. In vitro 
translation  of  electric  organ  mRNA  reveals  two  peptide 
precursors of the catalytic subunits (18), and RNase protec- 
tion analysis of electric organ mRNA reveals the presence of 
two major mRNA species that diverge in the region corre- 
sponding to the alternate third exon that gives rise to the two 
enzyme forms (16). These results support the hypothesis that 
both forms of the enzyme are synthesized by cells located in 
the electric organ.  However, the cDNA abundance  for the 
hydrophobic form is small when compared with the asym- 
metric form, supporting the hypothesis that the hydrophobic 
form is primarily synthesized in the electromotor neurons of 
the electric lobe (15, 19).  A more complete understanding of 
the alternative mRNA processing resulting in the different 
mRNA that code for the two forms of acetylcholinesterase 
will ultimately allow the generation of selective probes for 
in situ hydridization studies. Such studies may shed light on 
the cellular origin of the two forms of acetylcholinesterase. 
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